Insmed (INSM) News Today $76.54 +1.18 (+1.57%) (As of 02:26 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Readystate Asset Management LP Reduces Holdings in Insmed Incorporated (NASDAQ:INSM)Readystate Asset Management LP reduced its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 97.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 211,789 shares of the biopharmaceuticaDecember 5 at 6:29 AM | marketbeat.comRTW Investments LP Decreases Position in Insmed Incorporated (NASDAQ:INSM)RTW Investments LP trimmed its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.1% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,272,008 shares of the biopharmaceutical company's stoDecember 5 at 6:14 AM | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Purchased by Polar Asset Management Partners Inc.Polar Asset Management Partners Inc. increased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 217.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 57,500 shares of the biophaDecember 5 at 5:37 AM | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stock Holdings in Insmed Incorporated (NASDAQ:INSM)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 65.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owDecember 5 at 3:45 AM | marketbeat.comParkman Healthcare Partners LLC Has $2.59 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Parkman Healthcare Partners LLC decreased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 55.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 35,433 shares of the biopharmacDecember 4 at 8:00 AM | marketbeat.com171,704 Shares in Insmed Incorporated (NASDAQ:INSM) Bought by Patient Square Capital LPPatient Square Capital LP bought a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) during the third quarter, according to the company in its most recent disclosure with the SEC. The firm bought 171,704 shares of the biopharmaceutical company's stock, valued at approximatelDecember 4 at 7:48 AM | marketbeat.comBamco Inc. NY Buys Shares of 40,500 Insmed Incorporated (NASDAQ:INSM)Bamco Inc. NY purchased a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 40,500 shares of the biopharmaceutical company's stock, valued at approximately $2,956,000.December 4 at 5:19 AM | marketbeat.comCerity Partners LLC Grows Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Cerity Partners LLC increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 513.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 21,348 shares of the biopharDecember 4 at 3:39 AM | marketbeat.comHighVista Strategies LLC Lowers Stock Position in Insmed Incorporated (NASDAQ:INSM)HighVista Strategies LLC cut its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 64.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 45,447 shares of the biopharmaceutical company's stock aftDecember 3 at 7:10 AM | marketbeat.comCinctive Capital Management LP Sells 114,851 Shares of Insmed Incorporated (NASDAQ:INSM)Cinctive Capital Management LP lowered its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 78.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 30,706 shares of the biopharmaceutiDecember 3 at 6:34 AM | marketbeat.comErste Asset Management GmbH Invests $3.45 Million in Insmed Incorporated (NASDAQ:INSM)Erste Asset Management GmbH acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The fund acquired 47,600 shares of the biopharmaceutical company's stock, valued at approximately $3,450,000. ADecember 3 at 5:24 AM | marketbeat.comInsmed To Present at December 2024 Investor ConferencesDecember 2 at 8:00 AM | prnewswire.comBellevue Group AG Reduces Holdings in Insmed Incorporated (NASDAQ:INSM)Bellevue Group AG reduced its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 48.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 525,434 shares of the biopharmaceutical company's stock after selling 496,266 sharesDecember 1, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Holdings Raised by Eventide Asset Management LLCEventide Asset Management LLC increased its holdings in Insmed Incorporated (NASDAQ:INSM - Free Report) by 34.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 906,395 shares of the biopharmacNovember 29, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is Vestal Point Capital LP's Largest PositionVestal Point Capital LP increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 113.3% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,600,000 shares of the biopharmaceutical company's stock after purchasing an additional 850,November 29, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is Suvretta Capital Management LLC's 3rd Largest PositionSuvretta Capital Management LLC reduced its stake in Insmed Incorporated (NASDAQ:INSM - Free Report) by 35.1% during the third quarter, according to its most recent filing with the SEC. The fund owned 1,635,709 shares of the biopharmaceutical company's stock after selling 886,091 shares during theNovember 29, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Shares Bought by Ally Bridge Group NY LLCAlly Bridge Group NY LLC increased its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 16.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 150,833 shares of the biNovember 28, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is Acuta Capital Partners LLC's 4th Largest PositionAcuta Capital Partners LLC raised its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 49.1% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 107,500 shares of the biopharmaceutical company's sNovember 28, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Purchases 137,670 Shares of Insmed Incorporated (NASDAQ:INSM)Charles Schwab Investment Management Inc. raised its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.5% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,444,266 shares of tNovember 27, 2024 | marketbeat.comQsemble Capital Management LP Purchases Shares of 23,155 Insmed Incorporated (NASDAQ:INSM)Qsemble Capital Management LP acquired a new position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 23,155 shares ofNovember 26, 2024 | marketbeat.comNatixis Advisors LLC Makes New $1.53 Million Investment in Insmed Incorporated (NASDAQ:INSM)Natixis Advisors LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 20,894 shares of the biopharmaceutical company's stock, valued at approximately $1,525,000. SeveralNovember 26, 2024 | marketbeat.comLoomis Sayles & Co. L P Has $88.34 Million Holdings in Insmed Incorporated (NASDAQ:INSM)Loomis Sayles & Co. L P decreased its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 1.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,210,187 shares of thNovember 25, 2024 | marketbeat.com251,739 Shares in Insmed Incorporated (NASDAQ:INSM) Purchased by Westfield Capital Management Co. LPWestfield Capital Management Co. LP bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 251,739 shares of the biopharmaceutical company's stock, valued aNovember 25, 2024 | marketbeat.comAlgert Global LLC Reduces Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Algert Global LLC trimmed its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 49.5% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 81,501 shares of the biopharmaceutical company's stock after selling 79,874 shares during the period.November 24, 2024 | marketbeat.comIntech Investment Management LLC Invests $3.40 Million in Insmed Incorporated (NASDAQ:INSM)Intech Investment Management LLC bought a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 46,593 shares of the biopharmacNovember 24, 2024 | marketbeat.comB. Metzler seel. Sohn & Co. Holding AG Invests $767,000 in Insmed Incorporated (NASDAQ:INSM)B. Metzler seel. Sohn & Co. Holding AG acquired a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 10,510 shares of the biopharmaceuticaNovember 24, 2024 | marketbeat.comOptimistic Revenue Forecast for Insmed Following Brensocatib’s Launch and Strategic DevelopmentsNovember 23, 2024 | markets.businessinsider.comInsmed price target raised to $83 from $74 at JPMorganNovember 23, 2024 | markets.businessinsider.comEagle Asset Management Inc. Sells 51,455 Shares of Insmed Incorporated (NASDAQ:INSM)Eagle Asset Management Inc. lessened its position in Insmed Incorporated (NASDAQ:INSM - Free Report) by 16.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 263,235 shares of the biopharmaceutical company's stock after sellingNovember 23, 2024 | marketbeat.comInsmed (NASDAQ:INSM) Price Target Raised to $83.00 at JPMorgan Chase & Co.JPMorgan Chase & Co. boosted their price target on shares of Insmed from $74.00 to $83.00 and gave the stock an "overweight" rating in a report on Friday.November 22, 2024 | marketbeat.comSwiss National Bank Boosts Stake in Insmed Incorporated (NASDAQ:INSM)Swiss National Bank increased its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 9.0% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 302,500 shares of theNovember 22, 2024 | marketbeat.comBronchiectasis Market Size in the 7MM was ~USD 1,581.2 million in 2023, estimated DelveInsightNovember 21, 2024 | theglobeandmail.comInsmed’s Strategic Advancements and Promising Pipeline Justify Buy RatingNovember 21, 2024 | markets.businessinsider.comInsmed’s Strategic Growth and Market Potential Drive Buy RecommendationNovember 21, 2024 | markets.businessinsider.comInsmed Incorporated (NASDAQ:INSM) Stock Holdings Lifted by Jennison Associates LLCJennison Associates LLC lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 3.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 769,253 shares of the biopharmaceNovember 21, 2024 | marketbeat.comInsmed: PAH Treatment Advancement With 2nd Half 2025Â Top-Line DataNovember 20, 2024 | seekingalpha.comInsmed's Options: A Look at What the Big Money is ThinkingNovember 19, 2024 | benzinga.comInsmed (NASDAQ:INSM) Shares Gap Up - Here's WhyInsmed (NASDAQ:INSM) Shares Gap Up - Time to Buy?November 19, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) is First Turn Management LLC's 3rd Largest PositionFirst Turn Management LLC raised its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 10.2% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 356,451 shares of the biopharmaceutical company's stoNovember 19, 2024 | marketbeat.comOppenheimer Asset Management Inc. Grows Stake in Insmed Incorporated (NASDAQ:INSM)Oppenheimer Asset Management Inc. raised its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 115.7% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,449 shares of the biopNovember 19, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Receives Consensus Rating of "Buy" from BrokeragesShares of Insmed Incorporated (NASDAQ:INSM - Get Free Report) have been assigned an average rating of "Buy" from the sixteen analysts that are covering the company, MarketBeat reports. Sixteen analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokNovember 18, 2024 | marketbeat.comVictory Capital Management Inc. Buys 308,819 Shares of Insmed Incorporated (NASDAQ:INSM)Victory Capital Management Inc. lifted its stake in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 209.9% in the third quarter, according to its most recent filing with the SEC. The fund owned 455,959 shares of the biopharmaceutical company's stock after acquiring an additional 308,81November 17, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Stake Lifted by WCM Investment Management LLCWCM Investment Management LLC grew its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 58.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 148,330 shares of the biopharmaceutNovember 12, 2024 | marketbeat.comOptimistic Buy Rating for Insmed Driven by Brensocatib Growth Potential and Strong Financial PositionNovember 11, 2024 | markets.businessinsider.comTimesSquare Capital Management LLC Purchases Shares of 483,869 Insmed Incorporated (NASDAQ:INSM)TimesSquare Capital Management LLC purchased a new stake in Insmed Incorporated (NASDAQ:INSM - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 483,869 shares of the biopharmaceuticalNovember 10, 2024 | marketbeat.comPrincipal Financial Group Inc. Has $136.65 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)Principal Financial Group Inc. lifted its holdings in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 12.9% in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,871,890 shares of the biopharmaceutical company's stock after buyiNovember 9, 2024 | marketbeat.comInsmed Incorporated (NASDAQ:INSM) Position Cut by Fiera Capital CorpFiera Capital Corp lowered its position in shares of Insmed Incorporated (NASDAQ:INSM - Free Report) by 2.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 592,415 shares of the biopharmaceutical company's stock after selling 13,112 shares during the periodNovember 8, 2024 | marketbeat.comInsmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)November 7, 2024 | prnewswire.comVan ECK Associates Corp Acquires Shares of 127,024 Insmed Incorporated (NASDAQ:INSM)Van ECK Associates Corp bought a new position in Insmed Incorporated (NASDAQ:INSM - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 127,024 shares of the biopharmaceutical cNovember 7, 2024 | marketbeat.comInsmed To Present at November 2024 Investor ConferencesNovember 6, 2024 | prnewswire.com Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Why Trump's Win Can't Stop the Coming Crisis - Protect Yourself Now (Ad)We are soon facing one of the biggest transfers of wealth this country has ever seen. If you're not ready for what's coming, you risk losing everything. Everything you need to know - and how to protect yourself - is in my new emergency briefing. Watch my emergency briefing here >>> INSM Media Mentions By Week INSM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INSM News Sentiment▼1.530.79▲Average Medical News Sentiment INSM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INSM Articles This Week▼168▲INSM Articles Average Week Get Insmed News Delivered to You Automatically Sign up to receive the latest news and ratings for INSM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News Today Alnylam Pharmaceuticals News Today BeiGene News Today Teva Pharmaceutical Industries News Today United Therapeutics News Today Viatris News Today Royalty Pharma News Today Genmab A/S News Today Summit Therapeutics News Today BioMarin Pharmaceutical News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INSM) was last updated on 12/5/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEven Trump can’t stop what’s coming.No matter who sits in the White House over the next four years, a series of events has been triggered that cou...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Insmed Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Insmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INSM Stock Alerts